HIGHLIGHTS
- who: Xiaobei Yin and colleagues from the Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China have published the Article: Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis, in the Journal: Journal of Immunology Research of 15/04/2022
- what: This study found that the use of anti-VEGF inhibitors could yield better efficacious than non-anti-VEGF intervention on BCVA (in letters), or central macular thickness, and increased the incidence of gain of 15 or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.